CDSCO-2022-0053-V253
Type II variation for application CDSCO-2022-0053. Type II variation: Specification Change for Tiotropizone — critical change
Variation Number
CDSCO-2022-0053-V253
Type
Type II
Application
Change
Status
Overdue
Fee
€22,899
Submitted
—
Approved
—
Description
Type II variation: Specification Change for Tiotropizone — critical change